Inhibitory effects of apomorphine and pergolide on neurogenic vasoconstriction in the hindquarters of the rat
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 329 (2) , 146-151
- https://doi.org/10.1007/bf00501204
Abstract
The effects of locally administered apomorphine and pergolide were studied in the isolated autoperfused hindquarters of the rat, in an attempt to assess the possible role of presynaptic dopamine receptors at the level in the hypotensive effect of these dopamine agonists. Local infusion of apomorphine (1μg·kg−1·min−1 for 5 min) or pergolide (1μg·kg−1·min−1 for 5 min) [into the hindquarters] did not alter perfusion pressure per se, but reduced the pressor response to electrical stimulation of the lumbar sympathetic chains for the whole frequency range used during a cumulative frequency-response curve (0.25–16 Hz, 1 ms, supramaximal voltage). Apomorphine and pergolide reduced the pressor response elicited by 4 Hz electrical stimulation (applied until maximum response was reached) to 54.8±7.1% and 53.9±1.7% respectively, but they did not modify similar increases of perfusion pressure produced by locally administered noradrenaline. The inhibition by apomorphine and pergolide of the 4 Hz stimulation-evoked pressor response was completely antagonized by local administration of the dopamine antagonist haloperidol (1μg·kg−1), but was not influenced by the α2-antagonist rauwolscine (100μg·kg−1). This dose of rauwolscine antagonized the inhibitory effect of the α2-agonist UK-14,304, which was not influenced by haloperidol. Local administration of rauwolscine increased the pressor response to stimulation at 4 Hz by 37.4–46.2%. In contrast, local administration of haloperidol did not influence the 4 Hz stimulation-evoked pressor response. These results indicate that dopamine receptors are pressent on the sympathetic innervation of the vascular bed in the rat hindquarters but do not provide evidence for a physiological role of these receptors in modulating peripheral sympathetic neurotransmission. Stimulation of these receptors, leading to a decrease of noradrenaline release and thus of vasomotor tone, might—at least in part—explain the blood pressure lowering effects of intravenous apomorphine and pergolide in the rat.This publication has 36 references indexed in Scilit:
- Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part II: Sites and mechanisms of action of dopamine receptor agonistsLife Sciences, 1982
- CARDIOVASCULAR DOPAMINE RECEPTORS: PHYSIOLOGICAL, PHARMACOLOGICAL AND THERAPEUTIC IMPLICATIONSJournal of Autonomic Pharmacology, 1982
- Effects of Pergolide, A Dopamine Receptor Agonist, and Clondine on Cardiovascular Responses Evoked by Activation of Peripheral Sympathetic Outflow in RatsClinical and Experimental Hypertension. Part A: Theory and Practice, 1982
- Inhibitory effects of pergolide on peripheral adrenergic neurotransmission in spontaneously hypertensive ratsLife Sciences, 1981
- Pergolide: A potent dopaminergic antihypertensiveLife Sciences, 1979
- A Comparison of the Vascular Dopamine Receptor with Other Dopamine ReceptorsAnnual Review of Pharmacology and Toxicology, 1978
- Dopamine Receptor Stimulants in HypertensionActa Medica Scandinavica, 1977
- The cardiovascular effects of apomorphine in the anaesthetized ratEuropean Journal of Pharmacology, 1973
- Analysis of the effects of apomorphine and bulbocapnine in relation to the proposed dopamine receptorJournal of Pharmacy and Pharmacology, 1973